INTRODUCTION
Carcinoid tumors are low-grade tumors, exhibiting differentiation from neuroendocrine cells, with malignancy potential. Neuroendocrine cells in the body are also known are enterochromoffin cells or amine precursor uptake and decarboxylation cells (APUD) and they present in glandulous endocrine organs (like hypophysis, parathyroid, adrenal medulla). Neuroendocrine tumors (NETs) are most commonly present at gastrointestinal system by 73.7% and respiratory system by 25.1% where they rarely present in ovary, testis, cervix, breast, biliary tract and gall bladder (1, 2) . However, primary renal carcinoid tumor is a rare case and was firstly reported by Resnick in 1966 (1) . In this case report, we aimed to focus on a case with welldifferentiated primary neuroendocrine carcinoma of the kidney pathologically diagnosed after partial nephrectomy in horseshoe kidney.
CASE REPORT
In a 37-year-old woman patient, examined due to incidentally diagnosed splenomegaly, a horseshoe kidney with a hypodense area 18 x 12.5 mm in size at left kidney lower pole was observed by abdominal computed tomography (CT) scans. Abdominal magnetic resonance imaging (MRI) confirmed a pathological area 18 x 12.5 mm in size at left kidney lower pole, in venous phase monitoring at T2 sequence with mild hypointense signal, with a mild suspicious contrast and exhibiting diffusion limitation in diffusional examination (Figure 1 ney diagnosis (well-differentiated carcinoid tumor with trabecular and solid pattern) ( Figure 3 ). No pathology was observed at gastrointestinal system endoscopy, thorax computed tomography and 68Ga-DOTATATE positron emission tomography/computed tomography (PET/CT). Neuroendocrine tumor markers were not found in urine and blood. The patient was followed by diagnosis of primary neuroendocrine carcinoma of the kidney and during 6 months follow-up period no local relapse or systemic metastasis was observed.
DISCUSSION
Primary neuroendocrine carcinomas of the kidney are rare and their pathogenesis is still unknown as these tumors do not usually present in adult normal renal parenchyma, renal pelvis and ureter (2) . Unlike renal cell carcinoma, renal carcinoid tumor is observed at an early age and in most cases the age at diagnosis is about 49 years and no gender dominance is present. Symptoms (e.g. carcinoid syndrome) are rare and it is incidentally diagnosed in 25-30% of cases (2-4). They are clinically misdiagnosed with type 1 papillary renal cell carcinoma, mesonephric tumors, urothelial tumors, Wilms tumor and undifferentiated carcinoma (3). Primary neuroendocrine carcinoma of the kidney do not have specific CT or MRI imaging. In general, primary renal neuroendocrine tumors show a mild contrast uptake as it' s observed in radiological examinations of our case. Apart from this, it' s characterized by cystic mass and sometimes by calcification at CT (5, 6). The most dominant histological types of carcinoid tumors are trabecular or ribbon-like types. As a result of immunohistochemical studies, synaptophysin, chromogranin and CD56 showed positive and thyroid transcription factor (TTF-1), Wilms tumor protein (WT-1) and CDX2 showed negative (2, 7). Chromogranin, synaptophysin and CD56 positivities and CDX2 negativities of our case supported our neuroendocrine tumor diagnosis, and thus, we discarded renal cell carcinoma diagnosis. It' s known that primary neuroendocrine carcinomas of the kidney are frequently presented in kidneys with anomaly. So far in studies in the literature, 100 patients have been diagnosed by similar cases and it has been observed that tumor development mostly occurs in horseshoe kidney. The incidence of neuroendocrine carcinoma in horseshoe kidney is 62 times higher than in normal kidneys (8) . In their report examining clinical characteristics of 21 renal carcinoid tumors, Hansel et al. reported horseshoe kidney formation in 19% of the patients (7). Other kidney anomalies apart from horseshoe kidney are found as renal teratoma or teratoid malformation and polycystic kidney anomalies (1). Our case of primary neuroendocrine tumor 2 cm in size, diagnosed in horseshoe kidney supports the literature. Primary neuroendocrine carcinomas of the kidney are known to stem from neuroendocrine cells and be lowgrade malignancy potential tumors. To determine prognostic state of these tumors, some indicators and clinical findings are proposed. Aung et al. reported about morphologic and molecular structures of 11 well-differentiated renal carcinoid tumors showing that distant metastasis were not present in tumors 5 cm in size or ≤ 2 mitotic 10 HPF (3). In an other review, Romero et al. reported that 50% of cases was metastatic and of which 45.6% was at the time first diagnosis. They also stated that the risk of metastasis increases especially in patients over 40 years of age and with solid characterized and high mitotic activity tumors (2) . Complete surgical resection is the primary treatment against primary neuroendocrine tumors of the kidney. Partial nephrectomy might be applied depending on the size of the tumor (9) . Octreotide or 68Ga-DOTATATE PET/CT is offered during follow-up as useful diagnostic tool in order to diagnose residual or hidden metastatic carcinoid tissue after surgical resection (10) . Patients may develop local lymph node or distant organ metastasis after a long period of clinical course (7). In our study, a local tumor 2 cm in size with low mitotic index was diagnosed and no distant metastasis was present. During follow-up after partial nephrectomy, no local or systemic relapse was observed.
CONCLUSION
Primary neuroendocrine carcinoma of the kidney are rarely observed and treated by curative treatment after complete surgical resection and show low-grade malignancy potential. Its presence in kidneys with anomalies should be kept in mind and, if there is not a clear definitive diagnosis of other kidney masses, it should be taken into consideration.
